Orchestra BioMed Hldgs (OBIO) Stock Price, Quote, News & History | Benzinga

Orchestra BioMed Holdings Inc (OBIO) Stock Price, Quote, News & History

OBIONASDAQ

Trade with Public

Trade with Public

$5.44

0.081.49%

At close: Aug 24, 5:00 PM EST

$5.10

-0.34-6.25%

After Hours: 8:14 AM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$5.35

Close

$5.44

Volume / Avg.

249.53K / 339.96K

Day Range

$5.21 - $5.48

52 Wk Range

2.20 - 5.78

Market Cap

$306.54M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

74

Short Interest

6.55%

Days to Cover

13.37

Recent Orchestra Biomed Holdings Inc News

This Applied Materials Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday

Avi Kapoor

Why Power Solutions International Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

This Kopin Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Avi Kapoor

Orchestra BioMed Holdings, Inc. Stock Jumps 7.3%: Will It Continue to Soar?

Orchestra BioMed Holdings, Inc. (NASDAQ: OBIO) shares ended the last trading session 7.3% higher at $6.32. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 12.8% gain over the past four weeks.

Zacks

Top 4 Health Care Stocks That Should Keep You Up At Night

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-58.32M

Investing Cash Flow (TTM)

-69.29M

Financing Cash Flow (TTM)

129.33M

Free Cash Flow (TTM)

-59.10M

Capital Expenditure (TTM)

-781.00K

Net Change in Cash (TTM)

1.72M

Analyst Trends and Forecast

1

Mar

3

May

1

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$248.97M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

10.01

PB Ratio (TTM)

16.70

Earnings Yield % (TTM)

-15.64%

Earnings Yield % (FWD)

-28.31%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.32

Company Debt

Total Debt

$34.84M

LT Debt

$34.84M

LT Debt Issuance (TTM)

$20.00M

LT Debt Repayment (TTM)

-

Total Cash

$20.47M

Debt to Equity

1.87

Issuance of Debt (TTM)

$20.00M

Repayment of Debt (TTM)

-

Key Statistics

Open

$5.35

Close

$5.44

Volume / Avg.

249.53K / 339.96K

Day Range

$5.21 - $5.48

52 Wk Range

2.20 - 5.78

Market Cap

$306.54M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

74

Short Interest

6.55%

Days to Cover

13.37

About

Sector

Health Care

Industry

Health Care Equipment & Supplies

Orchestra BioMed Holdings Inc is a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships with medical device companies. The company's flagship product candidates are Atrioventricular Interval Mo...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Orchestra BioMed Hldgs (OBIO) stock?

A

You can purchase shares of Orchestra BioMed Hldgs (NASDAQ:OBIO) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Orchestra BioMed Hldgs (OBIO) competitors?

A

Other companies in Orchestra BioMed Hldgs’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Stryker Corp (NYSE:SYK), Medtronic PLC (NYSE:MDT) and Boston Scientific Corp (NYSE:BSX).

Q

What is the forecast, or price target, for Orchestra BioMed Hldgs (OBIO) stock?

A

Orchestra BioMed Hldgs has a consensus price target of $13.14.

Q

What is the current price for Orchestra BioMed Hldgs (OBIO)?

A

The stock price for Orchestra BioMed Hldgs (NASDAQ: OBIO) is $5.1 last updated August 24, 2026 at 8:14 AM EDT.

Q

Does Orchestra BioMed Hldgs (OBIO) pay a dividend?

A

There are no upcoming dividends for Orchestra BioMed Hldgs.

Q

When is Orchestra BioMed Hldgs (NASDAQ:OBIO) reporting earnings?

A

Orchestra BioMed Hldgs does not have any upcoming earnings scheduled.

Q

Is Orchestra BioMed Hldgs (OBIO) going to split?

A

There is no upcoming split for Orchestra BioMed Hldgs.

Q

What sector and industry does Orchestra BioMed Hldgs (OBIO) operate in?

A

Orchestra BioMed Hldgs is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.